Delivery Order SPE2DB20D1004-SPE2DB21FG0K8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,703.44 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of August 8, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award, valued at $3,074.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used for diabetes management. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,885.12 firm fixed-price delivery order is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,225.82, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used for the treatment of diabetes. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00. This IDC serves as the primary...
- This federal contract award, valued at $8,339.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4564512720 - TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award was made as a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,810.06, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used in the treatment of diabetes. The contract has an ultimate completion date of November 8, 2023, and is structured as a Firm Fixed Price Delivery Order. The contract was awarded on November 7, 2023, and does not have a set-aside...
- This federal contract award, valued at $1,552.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. This order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00, which enables the company to provide a comprehensive range of...
- This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of February 2, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $1,893.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4561807715 - TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes management medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
- This federal contract award, valued at $3,839.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4559143610 - TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a completion date of November 21, 2022 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FG0K8Delivery Order
This federal contract award, valued at $3,351.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of 4554699300 - TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication used in the treatment of diabetes. The contract is a firm-fixed-price delivery order with a completion date of September 9, 2021. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary mechanism for the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/8/21 |